帕金森病中的直立性低血压:一项7年前瞻性人群研究
该研究在新诊断且未用药的帕金森病人群队列中随访7年,重复测量卧立位血压。结果显示帕金森病患者直立性低血压发生率显著高于对照,7年累积患病率达65.4%,但抗低血压药物使用极少(0.5%)。
要点
- 帕金森病患者直立性低血压风险是对照的3.0倍(基线)至4.9倍(7年)。
- 7年累积直立性低血压患病率65.4%,临床显著直立性低血压29.2%,但治疗率仅0.5%。
- 年龄、认知下降、随访时间及左旋多巴等效剂量与直立性低血压相关。
核心结论
- 直立性低血压是早期帕金森病常见但治疗不足的并发症,与疾病症状和药物治疗相关,临床应更积极评估和管理。
研究设计与样本
- 前瞻性人群队列研究,纳入185例新诊断未用药帕金森病患者和172名匹配正常对照,重复进行卧立位血压测量,随访7年,采用广义估计方程模型分析。
主要发现
- 帕金森病患者所有访视时直立性低血压均比对照常见,相对风险从基线3.0(95%CI 1.6-5.8;p<0.001)升至7年后4.9(95%CI 2.4-10.1;p<0.001)。
- 7年累积直立性低血压患病率65.4%,临床显著直立性低血压(站立平均动脉压≤75 mm Hg)累积患病率29.2%,抗低血压药物使用率仅0.5%。
- 直立性低血压独立相关因素:年龄较大(每岁OR 1.06;95%CI 1.03-1.10)、较低简易智力状态检查评分(每单位OR 0.91;95%CI 0.85-0.97)、较长随访时间(每年OR 1.12;95%CI 1.03-1.23)。
- 临床显著直立性低血压与上述特征相关,此外还与较高左旋多巴等效剂量相关(每100 mg OR 1.16;95%CI 1.07-1.25)。
关键数值与推荐
- 直立性低血压采用共识标准判定,临床显著直立性低血压定义为站立位平均动脉压≤75 mm Hg。
临床怎么用
- 对帕金森病患者应定期进行卧立位血压测量,尤其对高龄、认知下降、随访时间长及左旋多巴等效剂量较高者。
- 直立性低血压在帕金森病中治疗率极低,需提高识别并积极管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the frequency, evolution, and associated features of orthostatic hypotension (OH) over 7 years of prospective follow-up in a population-based, initially drug-naive Parkinson disease (PD) cohort. METHODS: We performed repeated lying and standing blood pressure measurements in 185 patients with newly diagnosed PD and 172 matched normal controls to determine the occurrence of (1) OH using consensus-based criteria and (2) clinically significant OH (mean arterial pressure in standing position ≤75 mm Hg). We applied generalized estimating equations models for correlated data to investigate associated features of these 2 outcomes in patients with PD. RESULTS: OH was more common in patients with PD than controls at all visits, with the relative risk increasing from 3.0 (95% confidence interval [CI] 1.6-5.8; p < 0.001) at baseline to 4.9 (95% CI 2.4-10.1; p < 0.001) after 7 years. Despite a high cumulative prevalence of OH (65.4%) and clinically significant OH (29.2%), use of antihypotensive drugs was very rare (0.5%). OH was independently associated with older age (odds ratio [OR] 1.06 per year; 95% CI 1.03-1.10), lower Mini-Mental State Examination score (OR 0.91 [0.85-0.97] per unit), and longer follow-up time (OR 1.12 [1.03-1.23] per year). Clinically significant OH was associated with the same characteristics, in addition to higher levodopa equivalent dosage (OR 1.16 [1.07-1.25] per 100 mg). CONCLUSIONS: In this population-based study, we found OH to be a very frequent but undertreated complication in early PD, with associations to both disease-specific symptoms and drug treatment. Our findings suggest that clinicians should more actively assess and manage OH abnormalities in PD.
引用
- Hiorth YH, Pedersen KF, Dalen I, et al. Orthostatic hypotension in Parkinson disease: A 7-year prospective population-based study. Neurology. 2019. PMID: 31527282. doi:10.1212/WNL.0000000000008314
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。